🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

What you need to know about the coronavirus right now

Published 12/04/2021, 03:18 pm
Updated 12/04/2021, 07:30 pm
PFE
-
META
-
AZN
-

April 12 (Reuters) - Here's what you need to know about the coronavirus right now:

India's coronavirus tally overtakes Brazil's

India reported a record daily tally of 168,912 COVID-19 infections on Monday, the world's highest, while worries grew over a further spike, as hundreds of thousands of devotees gathered for a ritual bath in the Ganges river.

India now accounts for one in every six daily infections worldwide. Monday's new cases carried it past Brazil, for an overall tally of 13.53 million, data compiled by Reuters shows, placing it second after the United States, with 31.2 million.

A full opening of India's economy after last year's crippling lockdown, mass religious festivals and political rallies in states holding elections have worsened a second wave of infections, experts say. reports record cases

Thailand on Monday reported 985 new COVID-19 cases, a record daily jump for a second day in a row, as the country deals with a third wave of infections and a highly contagious variant.

Since the latest outbreak began at the start of April, 4,641 new domestic cases have been added in less than two weeks, bringing the total since last year to 33,610 cases and 97 deaths.

The spike comes ahead of the major national Songkran holidays, known for big street water fights that authorities have now banned for a second year due to the pandemic. considers mixing vaccines

China's top disease control official has said the country is formally considering mixing COVID-19 vaccines as a way of further boosting vaccine efficacy.

Available data shows Chinese vaccines lag behind others including Pfizer (NYSE:PFE) and Moderna in terms of efficacy, but require less stringent temperature controls during storage.

Giving people doses of different vaccines is one way to improve vaccines that "don't have very high rates of protection", Gao Fu, the director of the Chinese Centers for Disease Control and Prevention, said on Saturday, without specifying whether he was referring to foreign or domestic vaccines. abandons vaccination targets

Australia has abandoned a goal to vaccinate nearly all of its 26 million population by the end of 2021 following advice that people under the age of 50 take Pfizer's vaccine rather than AstraZeneca (NASDAQ:AZN)'s shot.

Australia, which had banked on the AstraZeneca vaccine for the majority of its shots, had no plans to set any new targets for completing its vaccination programme, Prime Minister Scott Morrison said.

Authorities changed their recommendation on Thursday, after European regulators reiterated the possibility of links between the AstraZeneca shot and reports of rare cases of blood clots. reopens with pints pulled, shopping sprees

People queued up outside retailers across England on Monday to release their pent-up shopping fever and some grabbed a midnight pint or even an early haircut as England's shops, pubs, gyms and hairdressers reopened after three months of lockdown.

After imposing the most onerous restrictions in Britain's peacetime history, Prime Minister Boris Johnson said the reopening was a "major step" towards freedom but urged people to behave responsibly as the coronavirus was still a threat.

Hundreds of thousands of businesses have been closed since early January when England entered a third lockdown to stem surging infections.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.